Six new Grand Challenges aim to tackle drug resistance and accelerate antibiotic discovery
News
Scottish Brain Sciences opens new Alzheimer’s research centre in Aberdeen
New ONE BioHub facility expands clinical trial access and strengthens Scotland’s brain health innovation
High dose nusinersen regimen receives positive CHMP opinion
New treatment option for spinal muscular atrophy moves closer to EU approval
Eisai shares long-term data on lecanemab at neurology congress
48-month analysis shows delayed progression and reduced risk in early Alzheimer’s patients
Mursla Bio partners with global pharma to advance precision medicine in liver disease
AI platform to support biomarker-guided therapy development in MASH
Evotec earns milestone payment as FDA clears IND for CELMoD candidate
US$5m payment from Bristol Myers Squibb marks progress in protein degradation partnership
Adocia unveils new long-acting peptide platform for diabetes and obesity
Patent filed for AdoXLong with promising monthly injection potential
Real-world data shows AUSTEDO improves life for patients with tardive dyskinesia
Findings highlight benefits in speech and daily activities alongside mental health stability
MSD’s oral cholesterol drug shows promise in late-stage trial
Enlicitide significantly reduces LDL-C in patients with high cardiovascular risk
MiNK Therapeutics unveils promising results for agenT-797 in resistant cancers
Allo-iNKT cell therapy shows durable survival and immune restoration in PD-1–refractory tumours
Procysbi approved for NHS Scotland use in rare kidney disorder
New treatment option offers hope for children with nephropathic cystinosis
Heidelberg Pharma sees promising results in multiple myeloma trial
Lead ATAC candidate HDP-101 shows strong clinical activity and safety in phase 8 cohort
Christie NHS Foundation Trust harnesses AI to revolutionise patient care
Real-time process mapping cuts manual workload and boosts frontline efficiency
Advanced therapies boost UK’s life sciences ambitions
CGT Catapult annual review shows sector’s impact on economy and patient access
Santhera reports promising long-term data for AGAMREE in Duchenne muscular dystrophy
Early treatment with vamorolone shows sustained efficacy and improved safety profile
